DOSING REGIMEN COMPRISING 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6- DIONE DERIVATIVES
The present disclosure relates to dosing regimens comprising 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione compounds or pharmaceutical compositions, pharmaceutical formulations, or combinations comprising the same; and methods of using such compounds, combinations, and compositions in the treatment o...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
24.01.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure relates to dosing regimens comprising 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione compounds or pharmaceutical compositions, pharmaceutical formulations, or combinations comprising the same; and methods of using such compounds, combinations, and compositions in the treatment or prevention IKAROS Family Zinc Finger 2 (IKZF2)-dependent diseases or disorders or where reduction of IKZF2 or IKZF4 protein levels can ameliorate a disease, for example, the treatment of cancers.
La presente invención se refiere a regímenes de dosificación que comprenden compuestos de 3-(1-oxoisoindolin-2-il)piperidina-2,6-di ona o composiciones farmacéuticas, formulaciones farmacéuticas o combinaciones que las comprenden; y métodos de uso de tales compuestos, combinaciones y composiciones en el tratamiento o prevención de enfermedades o trastornos dependientes de la proteína de dedos de zinc 2 de la Familia IKAROS (IKZF2) o donde la reducción de los niveles de proteína IKZF2 o IKZF4 puede mejorar una enfermedad, por ejemplo, el tratamiento de cánceres. |
---|---|
Bibliography: | Application Number: MX20220015852 |